HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,270,010 | -9.8% | 47,667 | -14.2% | 0.00% | – |
Q2 2023 | $4,732,166 | +22.2% | 55,581 | +18.8% | 0.00% | – |
Q1 2023 | $3,872,121 | +42.1% | 46,793 | +35.0% | 0.00% | – |
Q4 2022 | $2,725,773 | -68.8% | 34,657 | -70.6% | 0.00% | -100.0% |
Q3 2022 | $8,726,000 | +274.5% | 117,864 | +229.8% | 0.00% | – |
Q2 2022 | $2,330,000 | -22.9% | 35,736 | -25.2% | 0.00% | – |
Q1 2022 | $3,022,000 | -51.6% | 47,797 | -59.4% | 0.00% | – |
Q4 2021 | $6,240,000 | -47.3% | 117,662 | -29.8% | 0.00% | -100.0% |
Q3 2021 | $11,834,000 | -17.5% | 167,630 | -22.2% | 0.00% | -66.7% |
Q2 2021 | $14,351,000 | +271.5% | 215,338 | +518.8% | 0.00% | – |
Q1 2021 | $3,863,000 | -55.9% | 34,800 | -52.8% | 0.00% | – |
Q4 2020 | $8,756,000 | +23.3% | 73,724 | -9.4% | 0.00% | -100.0% |
Q3 2020 | $7,102,000 | +13.3% | 81,402 | +16.3% | 0.00% | 0.0% |
Q2 2020 | $6,266,000 | -51.4% | 69,969 | -45.9% | 0.00% | -75.0% |
Q1 2020 | $12,884,000 | +418.5% | 129,278 | +497.8% | 0.00% | – |
Q4 2019 | $2,485,000 | -72.1% | 21,624 | -69.4% | 0.00% | -100.0% |
Q3 2019 | $8,913,000 | -14.5% | 70,660 | -18.4% | 0.00% | +200.0% |
Q2 2019 | $10,422,000 | +705.4% | 86,630 | +485.3% | 0.00% | – |
Q1 2019 | $1,294,000 | +23.8% | 14,800 | +41.6% | 0.00% | – |
Q4 2018 | $1,045,000 | -26.4% | 10,449 | -15.7% | 0.00% | – |
Q3 2018 | $1,420,000 | -51.0% | 12,400 | -61.6% | 0.00% | -100.0% |
Q2 2018 | $2,898,000 | +483.1% | 32,310 | +375.1% | 0.00% | – |
Q1 2018 | $497,000 | -12.3% | 6,800 | -30.3% | 0.00% | – |
Q4 2017 | $567,000 | +27.4% | 9,759 | -13.3% | 0.00% | – |
Q2 2017 | $445,000 | -86.0% | 11,260 | -85.7% | 0.00% | -100.0% |
Q4 2016 | $3,169,000 | +605.8% | 78,842 | +535.8% | 0.00% | – |
Q3 2016 | $449,000 | +80.3% | 12,400 | +44.2% | 0.00% | – |
Q2 2016 | $249,000 | +16.4% | 8,600 | +29.5% | 0.00% | – |
Q4 2015 | $214,000 | -28.9% | 6,642 | -28.6% | 0.00% | – |
Q3 2015 | $301,000 | -86.0% | 9,306 | -82.1% | 0.00% | -100.0% |
Q2 2015 | $2,151,000 | +41.6% | 51,995 | +53.8% | 0.00% | 0.0% |
Q1 2015 | $1,519,000 | +60.7% | 33,816 | +33.8% | 0.00% | – |
Q4 2014 | $945,000 | +7.1% | 25,278 | +1.1% | 0.00% | – |
Q2 2014 | $882,000 | -44.1% | 24,992 | -48.3% | 0.00% | – |
Q1 2014 | $1,577,000 | +91.4% | 48,385 | +147.5% | 0.00% | – |
Q4 2013 | $824,000 | +266.2% | 19,550 | +246.1% | 0.00% | – |
Q3 2013 | $225,000 | – | 5,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |